Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NexgenRx Inc NEGXF


Primary Symbol: V.NXG

NexgenRx Inc. is a Canada-based independent full-service third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. It offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys single platform solution simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients. Its NexPension is an advanced pension administration solution designed to help sponsors record and tabulate contributions.


TSXV:NXG - Post by User

Comment by jcorobowon Apr 01, 2021 9:46am
198 Views
Post# 32921898

RE:NXG

RE:NXG Great results for the year. This years revenue was also impacted by reduction in claims due to people staying at home and not going to dentists, chiroporactors etc. Annual revenue (not including CEWS) was still up 10% even though revenue from some of their existing clients was reduced by the pandemic. Means they've been adding new customers. Should start to see this in 2021. Next year should see at least $3 million in quarterly revenue. 

The operating leverage in the business is immense. Incremental revenue for the most part flows straight to the bottom line as they have excess claims processing capacity. Allows them to price their service super competitively. Hoping to see further meaningful revenue growth in 2021 of at least 10%.

This is an interesting space. Telus health has a very similar product, I wouldn't be surprised if telus snaps them up.
<< Previous
Bullboard Posts
Next >>